An integrated fiberoptic–microfluidic device for agglutination detection and blood typing

In this paper, an integrated fiberoptic–microfluidic device for the detection of agglutination for blood type cross-matching has been described. The device consists of a straight microfluidic channel through with a reacted RBC suspension is pumped with the help of a syringe pump. The flow intersects an optical path created by an emitter-received fiber optic pair integrated into the microfluidic device. A 650 nm laser diode is used as the light source and a silicon photodiode is used to detect the light intensity. The spacing between the tips of the two optic fibers can be adjusted. When fiber spacing is large and the concentration of the suspension is high, scattering phenomenon becomes the dominant mechanism for agglutination detection while at low concentrations and small spacing, optointerruption becomes the dominant mechanism. An agglutination strength factor (ASF) is calculated from the data. Studies with a variety of blood types indicate that the sensing method correctly identifies the agglutination reaction in all cases. A disposable integrated device can be designed for future implementation of the method for near-bedside pre-transfusion check.

[1]  H. Oberman The present and future crossmatch , 1992, Transfusion.

[2]  S Andersson-Engels,et al.  T-matrix computations of light scattering by red blood cells. , 1998, Applied optics.

[3]  Physiology of Blood , 1998 .

[4]  P. Ingrand,et al.  Reliability of the pretransfusion bedside compatibility test: association with transfusion practice and training , 2008, Transfusion.

[5]  S. Narayanan,et al.  Ultraviolet and visible light spectrophotometric approach to blood typing: objective analysis by agglutination index , 1999, Transfusion.

[6]  A E Voytovich,et al.  Transfusion errors in New York State: an analysis of 10 years' experience , 2000, Transfusion.

[7]  P. Ingrand,et al.  Errors in Interpreting the Pretransfusion Bedside Compatibility Test , 2000 .

[8]  P. Ingrand,et al.  Errors in Interpreting the Pretransfusion Bedside Compatibility Test An Experimental Study , 2000, Vox Sanguinis.

[9]  D McRuer,et al.  Human error—a significant cause of transfusion mortality , 2000, Transfusion.

[10]  Virginie Migeot,et al.  Reliability of bedside ABO testing before transfusion , 2002, Transfusion.

[11]  I. Bromilow,et al.  The Rh Blood Group System , 2002 .

[12]  S. Narayanan,et al.  UV‐visible spectrophotometric approach to blood typing II: phenotyping of subtype A2 and weak D and whole blood analysis , 2002, Transfusion.

[13]  Walter H Dzik,et al.  Emily Cooley Lecture 2002: transfusion safety in the hospital , 2003, Transfusion.

[14]  K Sazama,et al.  Transfusion errors: scope of the problem, consequences, and solutions. , 2003, Current hematology reports.

[15]  Jeremy Lambert,et al.  Simplified spectraphotometric method for the detection of red blood cell agglutination. , 2008, Applied optics.